# LAT: Radioimmunoassay, Cannabinoid (S)

- Device class: 2; regulation: 21 CFR 862.3870; FDA's rule: 510(k) required
- FDA decisions: 16
- Recalls: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 1978: 1
- 1979: 1
- 1980: 1
- 1982: 3
- 1984: 2
- 1991: 5
- 1996: 2
- 2002: 1

## Most-cited predicates
- K961620: Abiscreen Online for Cannabinoids - ES 50/100 (1996), cited by 1
- K913414: Abuscreen (R) Online (TM) for THC (50/100)(100TEST KT (1991), cited by 1
- K011426: Psychemedics Ria Cannabinoid Assay (2002), cited by 1

Source page: https://510kreport.com/product-code/LAT
Data by year (CSV): https://510kreport.com/product-code/LAT.csv